Arca Biopharma Inc

General ticker "ABIO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $46.2M

Arca Biopharma Inc follows the US Stock Market performance with the rate: 41.2%.

Estimated limits based on current volatility of 10.7%: low 24.66$, high 30.58$

Factors to consider:

  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [16.55$, 39.56$]
  • 2024-12-30 to 2025-12-30 estimated range: [23.27$, 50.99$]

Financial Metrics affecting the ABIO estimates:

  • Negative: Non-GAAP EPS of -0.37 <= 0.08
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: negative Net Income
  • Negative: Operating Cash Flow per share of -0.35 <= 0.20
  • Negative: Industry Operating Cash Flow per share (median) of -1.55 <= 0.28
  • Positive: Interest Expense per share of 0 <= 0

Similar symbols

Short-term ABIO quotes

Long-term ABIO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $19.34MM $10.60MM $7.30MM
Operating Income $-19.34MM $-10.60MM $-7.30MM
Non-Operating Income $0.01MM $0.68MM $1.96MM
Interest Expense $0.00MM $0.68MM $0.00MM
R&D Expense $13.83MM $4.75MM $1.01MM
Income(Loss) $-19.32MM $-9.92MM $-5.34MM
Profit(Loss) $-19.32MM $-9.92MM $-5.34MM
Stockholders Equity $51.04MM $41.67MM $37.02MM
Assets $54.92MM $43.09MM $37.86MM
Operating Cash Flow $-18.76MM $-10.91MM $-5.01MM
Investing Cash Flow $-0.04MM $-0.00MM $0.00MM
Financing Cash Flow $23.09MM $0.00MM $0.00MM
Earnings Per Share* $-1.38 $-0.64 $-0.37

* EPS are Split Adjusted, recent splits may be reflected with a delay.